Hyperbaric-oxygen Therapy (HBOT) Versus Placebo for Treating Vaso-Occlusive Crisis (VOC) in Sickle Cell Disease (SCD)
Clinical trial NCT05289700 · UNKNOWN
Trial details
- NCT number
- NCT05289700
- Sponsor
- University Hospital, Geneva
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-15
- Primary completion
- 2024-09-15
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.